Hse et al evaluated risk factors for mortality in critically ill patients with systemic lupus erythematosus (SLE). This can help identify patients who may benefit from more aggressive therapy in the intensive care unit. The authors are from the National Taiwan University Hospital in Taipei, Taiwan.